Q2 EPS Estimates for TerrAscend Increased by Atb Cap Markets

Key Points

• Atb Cap Markets has upgraded its Q2 2025 EPS estimate for TerrAscend Corp. from ($0.03) to ($0.02) per share, maintaining a "Strong-Buy" rating on the stock.
• Despite the upgrade, TerrAscend reported a quarterly EPS of ($0.03), missing analysts' expectations by ($0.01) during their latest earnings announcement.
• As of now, TerrAscend's stock is trading at $0.51, with a market capitalization of $156.12 million and a 52-week trading range between $0.23 and $1.75.

TerrAscend Corp. (OTCMKTS:TSNDF - Free Report) - Stock analysts at Atb Cap Markets boosted their Q2 2025 earnings per share estimates for shares of TerrAscend in a research note issued to investors on Tuesday, August 5th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of ($0.02) for the quarter, up from their prior forecast of ($0.03). Atb Cap Markets has a "Strong-Buy" rating on the stock. The consensus estimate for TerrAscend's current full-year earnings is ($0.14) per share.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.01). TerrAscend had a negative return on equity of 21.15% and a negative net margin of 40.86%. The company had revenue of $65.01 million for the quarter, compared to the consensus estimate of $64.87 million.

TerrAscend Price Performance

Shares of TSNDF traded up $0.04 during midday trading on Friday, hitting $0.55. The company's stock had a trading volume of 855,846 shares, compared to its average volume of 550,775. TerrAscend has a one year low of $0.23 and a one year high of $1.75. The company's fifty day simple moving average is $0.34 and its two-hundred day simple moving average is $0.40. The company has a quick ratio of 0.70, a current ratio of 1.31 and a debt-to-equity ratio of 1.42. The stock has a market capitalization of $169.80 million, a price-to-earnings ratio of -1.35 and a beta of 1.39.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.